(VIANEWS) – VASTNED BELGIUM (VASTB.BR), TEXAF (TEXF.BR), MERCK AND CO INC (MRK.PA) are the highest payout ratio stocks on this list.
We have gathered information about stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. VASTNED BELGIUM (VASTB.BR)
78.85% Payout Ratio
Vastned Belgium is a public regulated real estate company (RREC), the shares of which are listed on Euronext Brussels (VASTB). Vastned Belgium invests exclusively in Belgian commercial real estate, more specifically in multi-functional retail properties located in the popular shopping cities of Antwerp, Brussels, Ghent and Bruges. The real estate portfolio also comprises high-end retail parks and retail warehouses. A smaller part of the portfolio is invested in hospitality and residential units.
Earnings Per Share
As for profitability, VASTNED BELGIUM has a trailing twelve months EPS of €2.79.
PE Ratio
VASTNED BELGIUM has a trailing twelve months price to earnings ratio of 10.39. Meaning, the purchaser of the share is investing €10.39 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.92%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VASTNED BELGIUM’s EBITDA is 61.86.
Yearly Top and Bottom Value
VASTNED BELGIUM’s stock is valued at €29.00 at 07:11 EST, way below its 52-week high of €34.10 and way above its 52-week low of €25.10.
Volume
Today’s last reported volume for VASTNED BELGIUM is 381 which is 53.81% below its average volume of 825.
Moving Average
VASTNED BELGIUM’s value is below its 50-day moving average of €30.36 and under its 200-day moving average of €29.90.
More news about VASTNED BELGIUM.
2. TEXAF (TEXF.BR)
62.66% Payout Ratio
Texaf S.A. develops, owns, and leases real estate properties in Kinshasa. It operates through Real Estate, Digital, and Quarries segments. The company's portfolio comprises 332 homes, including 53 villas and 289 apartments with a residential area of 62,200 square meters; 26,300 square meters of office and commercial space; and 30,000 square meters of warehouses, as well as TEXAF digital campus. It also supplies sandstones for use in concrete production, asphalt for roads, and civil engineering projects. Texaf S.A. was founded in 1925 and is headquartered in Brussels, Belgium. Texaf S.A. is a subsidiary of Société Financière Africaine.
Earnings Per Share
As for profitability, TEXAF has a trailing twelve months EPS of €2.28.
PE Ratio
TEXAF has a trailing twelve months price to earnings ratio of 15.79. Meaning, the purchaser of the share is investing €15.79 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.98%.
Moving Average
TEXAF’s value is higher than its 50-day moving average of €35.57 and higher than its 200-day moving average of €34.31.
Sales Growth
TEXAF’s sales growth for the current quarter is negative 5.2%.
Volume
Today’s last reported volume for TEXAF is 126 which is 63.47% below its average volume of 345.
More news about TEXAF.
3. MERCK AND CO INC (MRK.PA)
55.47% Payout Ratio
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Earnings Per Share
As for profitability, MERCK AND CO INC has a trailing twelve months EPS of €4.73.
PE Ratio
MERCK AND CO INC has a trailing twelve months price to earnings ratio of 22.2. Meaning, the purchaser of the share is investing €22.2 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.69%.
Volume
Today’s last reported volume for MERCK AND CO INC is 1032 which is 90.05% above its average volume of 543.
More news about MERCK AND CO INC.
4. ARCADIS (ARCAD.AS)
46.05% Payout Ratio
Arcadis NV offers design, engineering, and consultancy solutions for natural and built assets in The Americas, Europe, the Middle East, and the Asia Pacific. It operates through Places, Mobility, Resilience, and Intelligence segments. The company offers architectural and urbanism services; and asset management services, such as asset management strategy and planning, asset management decision making and operational optimization, life cycle planning and asset management systems, asset information/condition assessment, risk and review, organization and people, and asset management/O&M. It also provides business advisory services, including asset strategy and performance, business transformation and resiliency, investment and finance, operations and maintenance, and technology and information; contract solutions; cost and commercial management services; and design and engineering solutions for highways, railways, bridges, tunnels, power utilities, water utilities, ports and waterways, geotechnics, architecture, and structures, as well as building mechanical, electrical, and plumbing. In addition, the company offers digital environmental health safety and sustainability, environmental restoration, and project management solutions. Further, it provides mobility solutions for connected highways, intelligent rail and transit, integrated airports, and new mobility; places solutions; resilience solutions, including energy transition, climate adaption, water optimization, enviro socio permitting, sustainable advisory, environmental restoration, and sustainable operations; and water supply and treatment, distribution, resource management, and industrial water and wastewater services. The company was formerly known as Heidemij NV and changed its name to Arcadis N.V. in October 1997. Arcadis NV was founded in 1888 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ARCADIS has a trailing twelve months EPS of €1.52.
PE Ratio
ARCADIS has a trailing twelve months price to earnings ratio of 24.86. Meaning, the purchaser of the share is investing €24.86 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.1%.
Yearly Top and Bottom Value
ARCADIS’s stock is valued at €37.78 at 07:11 EST, way below its 52-week high of €43.70 and way higher than its 52-week low of €30.84.
Revenue Growth
Year-on-year quarterly revenue growth grew by 27%, now sitting on 4.03B for the twelve trailing months.
Sales Growth
ARCADIS’s sales growth for the next quarter is negative 3.2%.
More news about ARCADIS.
